Condition: Persistent Atrial Fibrillation Longstanding · Sponsor: Fundacion para la Innovacion en Biomedicina (FIBMED)
To assess the efficacy and safety of a percutaneous ablation strategy that targets multiple extrapulmonary structures as the Cox-Maze IV.
This description comes directly from the study's public registry record.
Angel Arenal, MD, PhD · 0034915868290 · arenal@secardiologia.es
Gonzalo Ricardo Ríos-Muñoz, MSc, PhD · grios@ing.uc3m.es
Always discuss trial participation with your own doctor first.
| Hospital General Universitario Gregorio Marañon | Madrid, Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07118488